Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecan

被引：22
|
作者：
Richards, S
Umbreit, JN
Fanucchi, MP
Giblin, J
Khuri, F
机构：
[1] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA
来源：
SOUTHERN MEDICAL JOURNAL | 2003年 / 96卷 / 10期
关键词：
citalopram; irinotecan; rhabdomyolysis; selective serotonin reuptake inhibitors;
D O I：
10.1097/01.SMJ.0000084311.35864.D6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 74-year-old man was admitted with rhabdomyolysis after undergoing initial treatment for gastrointestinal cancer with irinotecan. The syndrome partially resolved after the discontinuation of all of his usual medications, including his chronic selective serotonin reuptake inhibitor (SSRI). The rhabdomyolysis was exacerbated upon reinitiation of the SSRI and disappeared when the SSRI was discontinued. The combination of irinotecan and SSRI resulted in potentially lethal rhabdomyolysis.
引用
收藏
页码：1031 / 1033
页数：3
相关论文
共 50 条
  • [41] Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response
    Ji, Y.
    Biernacka, J.
    Snyder, K.
    Drews, M.
    Pelleymounter, L. L.
    Colby, C.
    Wang, L.
    Mrazek, D. A.
    Weinshilboum, R. M.
    PHARMACOGENOMICS JOURNAL, 2012, 12 (01) : 78 - 85
  • [42] Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review
    Fava, Giovanni A.
    Gatti, Alessia
    Belaise, Carlotta
    Guidi, Jenny
    Offidani, Emanuela
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2015, 84 (02) : 72 - 81
  • [43] Target brain sites of the anxiolytic effect of citalopram, a selective serotonin reuptake inhibitor
    Izumi, T
    Inoue, T
    Kitaichi, Y
    Nakagawa, S
    Koyama, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 534 (1-3) : 129 - 132
  • [44] Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia
    Bouwer, C
    Stein, DJ
    JOURNAL OF AFFECTIVE DISORDERS, 1998, 49 (01) : 79 - 82
  • [45] Drug interactions with antidepressants. Advantages of the selective serotonin reuptake inhibitor citalopram
    Eckert, A
    Reiff, J
    Muller, WE
    PSYCHOPHARMAKOTHERAPIE, 1998, 5 (01): : 8 - 18
  • [46] Fluoxetine, a selective serotonin reuptake inhibitor modulates inflammatory and neuropathic pain in the rat
    Singh V.P.
    Jain N.K.
    Kulkarni S.K.
    InflammoPharmacology, 2001, 9 (3) : 219 - 228
  • [47] Effects of Selective Serotonin Reuptake Inhibitor Treatment on Ovarian Reserves in Patients with Depression
    Gok, Soner
    Gok, Berfin Can
    Alatas, Erkan
    Senol, Hande
    Topak, Osman Zuelkif
    MEDICINA-LITHUANIA, 2023, 59 (03):
  • [48] Successful use of a selective serotonin reuptake inhibitor in a patient with multiple chemical sensitivities
    Andine, P
    Ronnback, L
    Jarvholm, B
    ACTA PSYCHIATRICA SCANDINAVICA, 1997, 96 (01) : 82 - 83
  • [49] Selective serotonin reuptake inhibitor utilization patterns: Consistency across research designs
    Hutchins, DS
    Klein, EG
    Signa, WF
    Young, CH
    Gregor, KJ
    CLINICAL THERAPEUTICS, 1998, 20 (04) : 797 - 805
  • [50] Clickable photoaffinity ligands for the human serotonin transporter based on the selective serotonin reuptake inhibitor (S)-citalopram
    Yarravarapu, Nageswari
    Geffert, Laura
    Surratt, Christopher K.
    Cascio, Michael
    Lapinsky, David J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (21) : 3431 - 3435
12345